Valuation: Kenvue Inc.

Market Cap 36.29B 31.89B 29.64B 27.26B 51.11B 3,504B 52.08B 354B 138B 1,717B 136B 133B 5,945B P/E 2026 *
19.8x
P/E 2027 * 17.7x
Enterprise Value 43.69B 38.4B 35.68B 32.82B 61.54B 4,219B 62.71B 426B 166B 2,068B 164B 160B 7,158B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.69x
Free-Float
98.9%
Yield 2026 *
4.49%
Yield 2027 * 4.59%
1 day+0.69%
1 week+1.07%
Current month-1.10%
1 month+5.82%
3 months+9.19%
6 months+6.48%
Current year+9.57%
1 week 18.77
Extreme 18.77
19.36
1 month 18.46
Extreme 18.46
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.87
3 years 14.02
Extreme 14.02
25.23
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
6/29/26
Starboard Value LP
OtherCompany 1,413 0.0001%
6/29/26 Free

Director

1,413 0.0001%
6/10/26 Sell

Chief Financial Officer

-3,700 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%+1.07%-16.63%-21.28% 36.73B
-1.45%-0.73%-7.17%-3.90% 347B
-1.54%-0.34%-9.21%-1.07% 133B
-1.69%-1.52%+1.56%+16.70% 73.32B
+0.33%+2.82%-12.82%-16.98% 52.46B
-3.28%-2.90%-10.20%-55.52% 29.9B
-1.24%-1.22%-28.48%-32.81% 19.63B
-2.28%-1.72%+11.38%+5.02% 19.62B
-0.19%-1.80%-3.05%+23.79% 17.91B
-0.95%+0.56%-14.79%+0.19% 11.33B
Average -1.02%+0.78%-8.94%-8.59% 74.11B
Weighted average by Cap. -0.64%+0.88%-7.75%-5.02%

Financials

2026 *2027 *
Net sales 15.63B 13.73B 12.76B 11.74B 22.01B 1,509B 22.42B 152B 59.4B 739B 58.63B 57.39B 2,560B 16.02B 14.08B 13.08B 12.03B 22.56B 1,547B 22.99B 156B 60.91B 758B 60.12B 58.84B 2,625B
Net income 1.84B 1.62B 1.51B 1.38B 2.6B 178B 2.64B 17.97B 7.01B 87.2B 6.92B 6.77B 302B 2.06B 1.81B 1.69B 1.55B 2.91B 199B 2.96B 20.14B 7.85B 97.7B 7.75B 7.58B 338B
Net Debt 7.41B 6.51B 6.05B 5.56B 10.43B 715B 10.63B 72.23B 28.16B 350B 27.79B 27.2B 1,213B 6.81B 5.99B 5.56B 5.12B 9.59B 658B 9.77B 66.42B 25.89B 322B 25.56B 25.01B 1,116B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-07-23 US$18.90 -1.20% 14,409,959
26-07-22 US$19.13 +0.63% 9,899,890
26-07-21 US$19.01 -0.05% 12,703,960
26-07-20 US$19.02 +0.21% 12,222,234
26-07-17 US$18.98 -0.21% 29,311,427
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.90USD
Average target price
19.83USD
Spread / Average Target
+4.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock